(Q54388215)

29 May 2018

title

Cyclosporine A induced remission of relapsing nephrotic syndrome in children. (English)

1 reference

29 May 2018

1 reference

1 reference

Tejani AT

1

1 reference

29 May 2018

Butt K

2

1 reference

29 May 2018

Trachtman H

3

1 reference

29 May 2018

Suthanthiran M

4

1 reference

29 May 2018

Rosenthal CJ

5

1 reference

29 May 2018

Khawar MR

6

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 March 1988

1 reference

29 May 2018

published in

Kidney International

1 reference

29 May 2018

volume

33

1 reference

29 May 2018

issue

3

1 reference

29 May 2018

page(s)

729-734

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1038/ki.1988.59

exact match

0 references

cites work

Long-term assessment of steroid therapy in childhood nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

A reappraisal of the effects of monoclonal antibodies directed at T cell differentiation antigens

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Long-term outcome for children with minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Pathogenesis of lipoid nephrosis: a disorder of T-cell function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Lymphocytotoxins in primary renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Characteristics of cyclosporine induction of increased prostaglandin levels from human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Effect of cyclosporine administration on renal hemodynamics in conscious rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Cyclosporin in the treatment of idiopathic nephrotic syndrome in children.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Glucocorticosteroids and organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Long-Term Evaluation of Children with Nephrotic Syndrome and Focal Segmental Glomerular Sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1988.59

7 January 2021

Identifiers

DOI

10.1038/KI.1988.59

1 reference

29 May 2018

1 reference

29 May 2018